Many are focusing on the AGM request for bump up of % of options. Ie more insider shares.
All of which is 100% irrelevant if onc Pelareorep fails or passes to get to phase 3 registration.
" shareholder value" is directly related to the business opportunities of Pela.
Yes, I get the math ..dillution etc etc.
however. If they get Pela to market the potential is a multi- billion $$ , company..
if they don't, then not much more than where it is.
We need to dig deep into motivation behind two related requests .
One, the " opportunity" to increase the BOD by 4 more directors.
Two, The request to increase availability of options for directors/ management.
Why, why, why ...would a potentially failing company want to increase insider share count for a failing company.?
Answer ( my thesis) as follows.
A partnership or similar type of deal, would require as part of that deal. The partner pharma to have in- place seats on the BOD of oncolitics biotech.
Hence the request for the " option" to increase the size of BOD.
Additionally , " they" don't take on these appointments for free.
Share " options" are the least costly compensation available.
Should Onc reach phase 3 registration etc etc, the SP will climb.
The options will be excercised, More insider % of holdings... which is what many have been asking for a very long time.
Should Onc fail. The options will not be exercised & the whole process irrelevant.
ask yourself......Are they going through this process expecting to fail?
obviously not.
bottom line.
There are numbers & updates long over due.
speculate all we want. Good or bad. We do not know.
All of the clues point to a positive future.
( the SP contrary to what people say, is not an indication of Pela success) it is however tied to lack of data, speculation, fear of the unknown & a long history of disappointments.
Not to mention the " market" in general is very rocky.